ETR:SBS - Stratec Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add €65.90 -1.90 (-2.80 %) (As of 02/26/2020 03:38 PM ET) Add Compare Today's Range€61.50Now: €65.90▼€66.5050-Day Range€61.30MA: €65.58▼€69.2052-Week Range€52.30Now: €65.90▼€77.60Volume12,316 shsAverage Volume6,253 shsMarket Capitalization$793.87 millionP/E Ratio77.99Dividend Yield1.18%BetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. Read More… Industry, Sector and Symbol Stock Exchange ETR Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolETR:SBS Previous Symbol CUSIPN/A CIKN/A Webhttp://www.stratec.com/ Phone+49-7082-79160Debt Debt-to-Equity Ratio59.01 Current Ratio2.93 Quick Ratio1.59Price-To-Earnings Trailing P/E Ratio77.99 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$214.25 million Price / Sales3.71 Cash Flow€1.39 per share Price / Cash Flow47.51 Book Value€12.57 per share Price / Book5.24Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,158 Outstanding Shares12,046,600Market Cap$793.87 million Next Earnings Date4/2/2020 (Estimated) OptionableOptionable Receive SBS News and Ratings via Email Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter. SBS Rates by TradingView Stratec (ETR:SBS) Frequently Asked Questions What is Stratec's stock symbol? Stratec trades on the ETR under the ticker symbol "SBS." When is Stratec's next earnings date? Stratec is scheduled to release their next quarterly earnings announcement on Thursday, April 2nd 2020. View Earnings Estimates for Stratec. What price target have analysts set for SBS? 3 brokerages have issued 1-year price objectives for Stratec's shares. Their forecasts range from €66.00 to €74.00. On average, they expect Stratec's share price to reach €70.33 in the next year. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Price Targets for Stratec. What is the consensus analysts' recommendation for Stratec? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stratec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stratec. Has Stratec been receiving favorable news coverage? News stories about SBS stock have trended positive on Wednesday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stratec earned a media sentiment score of 2.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Stratec. Who are some of Stratec's key competitors? Some companies that are related to Stratec include Avita Medical (AVH), Zynex (ZYXI), Draegerwerk AG & Co KGaA (DRW3), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Electromed (ELMD), Electromed (ELMD), Cyclopharm (CYC), Advanced Oncotherapy (AVO), MRI Interventions (MRIC), Patient Home Monitoring (PTQ), REVA Medical (RVA) and Kromek Group (KMK). What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Payment Data Systems (PYDS), PetIQ (PETQ), Ollie's Bargain Outlet (OLLI), Masimo (MASI), HD Supply (HDS), Gogo (GOGO), Depomed (DEPO), Apptio (APTI), Align Technology (ALGN) and Marks and Spencer Group (MKS). Who are Stratec's key executives? Stratec's management team includes the folowing people: Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 52)Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 52)Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 52)Mr. Hermann Leistner, Founder & Advisor (Age 73)Sandra Eberle, Head of Investor Relations What is Stratec's stock price today? One share of SBS stock can currently be purchased for approximately €65.90. How big of a company is Stratec? Stratec has a market capitalization of $793.87 million and generates $214.25 million in revenue each year. Stratec employs 1,158 workers across the globe.View Additional Information About Stratec. What is Stratec's official website? The official website for Stratec is http://www.stratec.com/. How can I contact Stratec? Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160. MarketBeat Community Rating for Stratec (ETR SBS)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 133 (Vote Outperform)Underperform Votes: 106 (Vote Underperform)Total Votes: 239MarketBeat's community ratings are surveys of what our community members think about Stratec and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/26/2020 by MarketBeat.com StaffFeatured Article: Learning About the VIX - Volatility Index
